Exact Sciences' price target hits $29

Ten financial analysts have updated their short term price target for Exact Sciences, the company that developed Cologuard, according to an MFI report.

The company's short term price target estimate is $29, according to the report. On the low end, the price target could be $12. On the high end, the price target could be $37, according to the report.

Exact Sciences has a market cap of $2.03 billion.

More articles on gastroenterology:
8 payment updates for gastroenterologists to know
FDA sends warning letters to 3 major scope manufacturers
Company behind Cologuard wins innovation award

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers